Literature DB >> 33922310

Tetracalcium Phosphate/Monetite/Calcium Sulfate Hemihdrate Biocement Powder Mixtures Prepared by the One-Step Synthesis for Preparation of Nanocrystalline Hydroxyapatite Biocement-Properties and In Vitro Evaluation.

Lubomir Medvecky1, Maria Giretova1, Radoslava Stulajterova1, Lenka Luptakova2, Tibor Sopcak1.   

Abstract

A modified one-step process was used to prepare tetracalcium phosphate/monetite/calcium sulfate hemihydrate powder cement mixtures (CAS). The procedure allowed the formation of monetite and calcium sulfate hemihydrate (CSH) in the form of nanoparticles. It was hypothesized that the presence of nanoCSH in small amounts enhances the in vitro bioactivity of CAS cement in relation to osteogenic gene markers in mesenchymal stem cells (MSCs). The CAS powder mixtures with 15 and 5 wt.% CSH were prepared by milling powder tetracalcium phosphate in an ethanolic solution of both orthophosphoric and sulfuric acids. The CAS cements had short setting times (around 5 min). The fast setting of the cement samples after the addition of the liquid component (water solution of NaH2PO4) was due to the partial formation of calcium sulfate dihydrate and hydroxyapatite before soaking in SBF with a small change in the original phase composition in cement powder samples after milling. Nanocrystalline hydroxyapatite biocement was produced by soaking of cement samples after setting in simulated body fluid (SBF). The fast release of calcium ions from CAS5 cement, as well as a small rise in the pH of SBF during soaking, were demonstrated. After soaking in SBF for 7 days, the final product of the cement transformation was nanocrystalline hydroxyapatite. The compressive strength of the cement samples (up to 30 MPa) after soaking in simulated body fluid (SBF) was comparable to that of bone. Real time polymerase chain reaction (RT-PCR) analysis revealed statistically significant higher gene expressions of alkaline phosphatase (ALP), osteonectin (ON) and osteopontin (OP) in cells cultured for 14 days in CAS5 extract compared to CSH-free cement. The addition of a small amount of nanoCSH (5 wt.%) to the tetracalcium phosphate (TTCP)/monetite cement mixture significantly promoted the over expression of osteogenic markers in MSCs. The prepared CAS powder mixture with its enhanced bioactivity can be used for bone defect treatment and has good potential for bone healing.

Entities:  

Keywords:  calcium phosphate cement; gene expression; hemihydrate calcium sulfate; mesenchymal stem cells; microstructure; setting process

Year:  2021        PMID: 33922310     DOI: 10.3390/ma14092137

Source DB:  PubMed          Journal:  Materials (Basel)        ISSN: 1996-1944            Impact factor:   3.623


  35 in total

1.  Deriving fast setting properties of tetracalcium phosphate/dicalcium phosphate anhydrous bone cement with nanocrystallites on the reactant surfaces.

Authors:  Jen-Chyan Wang; Chia-Ling Ko; Chun-Cheng Hung; Yu-Chang Tyan; Chern-Hsiung Lai; Wen-Cheng Chen; Chih-Kuang Wang
Journal:  J Dent       Date:  2009-10-09       Impact factor: 4.379

2.  Bioactive tetracalcium phosphate/magnesium phosphate composite bone cement for bone repair.

Authors:  Jingxian Liu; Jianguo Liao; Yanqun Li; Zhengpeng Yang; Qiwei Ying; Yufen Xie; Aiguo Zhou
Journal:  J Biomater Appl       Date:  2019-05-01       Impact factor: 2.646

3.  Synthesis of biomimetic Ca-hydroxyapatite powders at 37 degrees C in synthetic body fluids.

Authors:  A C Tas
Journal:  Biomaterials       Date:  2000-07       Impact factor: 12.479

4.  The kinetics of remodeling of a calcium sulfate/calcium phosphate bioceramic.

Authors:  Roberto Civinini; Antonio Capone; Christian Carulli; Fabrizio Matassi; Lorenzo Nistri; Massimo Innocenti
Journal:  J Mater Sci Mater Med       Date:  2017-08-07       Impact factor: 3.896

5.  Modulation of porosity in apatitic cements by the use of alpha-tricalcium phosphate-calcium sulphate dihydrate mixtures.

Authors:  Enrique Fernández; Maria Daniela Vlad; Maria Montserrat Gel; Jose López; Ricardo Torres; Juan V Cauich; Marc Bohner
Journal:  Biomaterials       Date:  2005-06       Impact factor: 12.479

6.  Study on injectable and degradable cement of calcium sulphate and calcium phosphate for bone repair.

Authors:  Gangfeng Hu; Luwei Xiao; Hong Fu; Dawei Bi; Haitao Ma; Peijian Tong
Journal:  J Mater Sci Mater Med       Date:  2009-10-13       Impact factor: 3.896

7.  Variation in structure and properties of a non-dispersive TTCP/DCPA-derived CPC immersed in Hanks' solution.

Authors:  W C Chen; C P Ju; J H Chern Lin
Journal:  J Oral Rehabil       Date:  2007-07       Impact factor: 3.837

8.  Characterization of Properties, In Vitro and In Vivo Evaluation of Calcium Phosphate/Amino Acid Cements for Treatment of Osteochondral Defects.

Authors:  Lubomir Medvecky; Maria Giretova; Radoslava Stulajterova; Jan Danko; Katarina Vdoviakova; Lenka Kresakova; Zdenek Zert; Eva Petrovova; Katarina Holovska; Maros Varga; Lenka Luptakova; Tibor Sopcak
Journal:  Materials (Basel)       Date:  2021-01-17       Impact factor: 3.623

9.  Isolation and Characterisation of Mesenchymal Stem Cells from Rat Bone Marrow and the Endosteal Niche: A Comparative Study.

Authors:  Norhayati Yusop; Paul Battersby; Amr Alraies; Alastair J Sloan; Ryan Moseley; Rachel J Waddington
Journal:  Stem Cells Int       Date:  2018-03-22       Impact factor: 5.443

10.  Tissue reaction and material biodegradation of a calcium sulfate/apatite biphasic bone substitute in rat muscle.

Authors:  Jian-Sheng Wang; Magnus Tägil; Hanna Isaksson; Mathias Boström; Lars Lidgren
Journal:  J Orthop Translat       Date:  2015-12-19       Impact factor: 5.191

View more
  1 in total

1.  Characterization of Tetracalcium Phosphate/Monetite Biocement Modified by Magnesium Pyrophosphate.

Authors:  Radoslava Stulajterova; Lubomir Medvecky; Maria Giretova; Tibor Sopcak; Lenka Luptakova; Radovan Bures; Eva Szekiova
Journal:  Materials (Basel)       Date:  2022-03-31       Impact factor: 3.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.